IRulya Therapeutics QNCX
NASDAQ QNCX
$34.45 +2.42 (+7.56%)
At close: Oct 19, 2026 · 4:00 PM EDT

Quince Therapeutics, Inc. (QNCX) Debt Ratio (2023 - 2025)

Updated

Quince Therapeutics' (QNCX) Debt Ratio stood at 0.19 in Q4 2025, up 20.9% from the prior quarter.

Analysis

Quince Therapeutics, Inc. (QNCX) Debt Ratio (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.19
Sep 30, 2025 0.16
Jun 30, 2025 0.14
Mar 31, 2025 0.14
Sep 30, 2024 0.12
Jun 30, 2024 0.10
Mar 31, 2024 0.08
Dec 31, 2023 0.08
API Access

Quince Therapeutics, Inc. Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=QNCX&period=max&api_key=YOUR_API_KEY